Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.13 Billion MYR | -14.21% |
| 2022 | 1.32 Billion MYR | -48.35% |
| 2021 | 2.56 Billion MYR | 1.88% |
| 2020 | 2.51 Billion MYR | -19.75% |
| 2019 | 3.13 Billion MYR | 8.94% |
| 2018 | 2.87 Billion MYR | 211.42% |
| 2017 | 923.77 Million MYR | 12.2% |
| 2016 | 823.3 Million MYR | -23.31% |
| 2015 | 1.07 Billion MYR | 100.43% |
| 2014 | 535.61 Million MYR | 29.51% |
| 2013 | 413.58 Million MYR | 29.98% |
| 2012 | 318.19 Million MYR | 15.02% |
| 2011 | 276.65 Million MYR | 8.22% |
| 2010 | 255.64 Million MYR | -10.75% |
| 2009 | 286.43 Million MYR | -32.25% |
| 2008 | 422.75 Million MYR | 1.5% |
| 2007 | 416.49 Million MYR | -12.87% |
| 2006 | 478 Million MYR | 57.86% |
| 2005 | 302.81 Million MYR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.25 Billion MYR | -8.05% |
| 2024 Q1 | 1.14 Billion MYR | 0.81% |
| 2024 Q2 | 2.34 Billion MYR | 2.09% |
| 2023 Q2 | 1.1 Billion MYR | 2.55% |
| 2023 Q1 | 1.08 Billion MYR | -18.35% |
| 2023 Q3 | 1.21 Billion MYR | 9.75% |
| 2023 FY | 1.13 Billion MYR | -14.21% |
| 2023 Q4 | 1.13 Billion MYR | -6.64% |
| 2022 Q3 | 1.61 Billion MYR | -6.79% |
| 2022 FY | 1.32 Billion MYR | -48.35% |
| 2022 Q1 | 2.06 Billion MYR | -19.51% |
| 2022 Q4 | 1.32 Billion MYR | -17.91% |
| 2022 Q2 | 1.72 Billion MYR | -16.13% |
| 2021 Q2 | 4.21 Billion MYR | 24.63% |
| 2021 Q4 | 2.56 Billion MYR | -37.86% |
| 2021 FY | 2.56 Billion MYR | 1.88% |
| 2021 Q3 | 4.12 Billion MYR | -2.16% |
| 2021 Q1 | 3.38 Billion MYR | 34.45% |
| 2020 FY | 2.51 Billion MYR | -19.75% |
| 2020 Q1 | 3.25 Billion MYR | 4.0% |
| 2020 Q3 | 2.71 Billion MYR | -14.49% |
| 2020 Q4 | 2.51 Billion MYR | -7.19% |
| 2020 Q2 | 3.16 Billion MYR | -2.77% |
| 2019 Q4 | 3.13 Billion MYR | 2.8% |
| 2019 FY | 3.13 Billion MYR | 8.94% |
| 2019 Q1 | 2.88 Billion MYR | 0.2% |
| 2019 Q3 | 3.04 Billion MYR | 8.55% |
| 2019 Q2 | 2.8 Billion MYR | -2.57% |
| 2018 Q1 | 874.8 Million MYR | -5.3% |
| 2018 Q4 | 2.87 Billion MYR | 3.32% |
| 2018 Q3 | 2.78 Billion MYR | 142.26% |
| 2018 FY | 2.87 Billion MYR | 211.42% |
| 2018 Q2 | 1.14 Billion MYR | 31.38% |
| 2017 Q2 | 871.06 Million MYR | 3.94% |
| 2017 Q1 | 838.08 Million MYR | 1.8% |
| 2017 Q3 | 883.57 Million MYR | 1.44% |
| 2017 FY | 923.77 Million MYR | 12.2% |
| 2017 Q4 | 923.77 Million MYR | 4.55% |
| 2016 FY | 823.3 Million MYR | -23.31% |
| 2016 Q4 | 823.3 Million MYR | -8.26% |
| 2016 Q3 | 897.38 Million MYR | -1.75% |
| 2016 Q2 | 913.36 Million MYR | -7.25% |
| 2016 Q1 | 984.78 Million MYR | -8.27% |
| 2015 Q3 | 974.92 Million MYR | 21.98% |
| 2015 FY | 1.07 Billion MYR | 100.43% |
| 2015 Q1 | 712.73 Million MYR | 33.07% |
| 2015 Q2 | 799.22 Million MYR | 12.14% |
| 2015 Q4 | 1.07 Billion MYR | 10.11% |
| 2014 Q1 | 349.53 Million MYR | -15.49% |
| 2014 Q3 | 628.9 Million MYR | 23.52% |
| 2014 Q2 | 509.17 Million MYR | 45.67% |
| 2014 FY | 535.61 Million MYR | 29.51% |
| 2014 Q4 | 535.61 Million MYR | -14.83% |
| 2013 Q4 | 413.58 Million MYR | 8.15% |
| 2013 Q2 | 354.16 Million MYR | 6.51% |
| 2013 Q1 | 332.5 Million MYR | 4.5% |
| 2013 FY | 413.58 Million MYR | 29.98% |
| 2013 Q3 | 382.41 Million MYR | 7.98% |
| 2012 FY | 318.19 Million MYR | 15.02% |
| 2012 Q3 | 380.16 Million MYR | 25.81% |
| 2012 Q2 | 302.17 Million MYR | 0.0% |
| 2012 Q4 | 318.19 Million MYR | -16.3% |
| 2011 Q4 | 276.65 Million MYR | 0.0% |
| 2011 FY | 276.65 Million MYR | 8.22% |
| 2010 FY | 255.64 Million MYR | -10.75% |
| 2009 FY | 286.43 Million MYR | -32.25% |
| 2008 FY | 422.75 Million MYR | 1.5% |
| 2007 FY | 416.49 Million MYR | -12.87% |
| 2006 FY | 478 Million MYR | 57.86% |
| 2005 FY | 302.81 Million MYR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -48220.442% |
| Ansell Limited | 1.32 Billion USD | 14.621% |
| Ansell Limited | 1.33 Billion USD | 14.781% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -798.746% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -120286.844% |
| Psykey, Inc. | 2.47 Million USD | -45795.161% |
| ConvaTec Group Plc | 2.01 Billion USD | 43.738% |
| ConvaTec Group Plc | 2.02 Billion USD | 43.817% |
| Encision Inc. | 1.98 Million USD | -57131.518% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -37244.609% |
| Innovative MedTech Inc. | 6.13 Million USD | -18408.298% |
| LifePoint, Inc. | 2.45 Million USD | -46166.374% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -11052.686% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -33295.735% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -37246.525% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -146159.511% |
| SmileDirectClub, Inc. | 982.26 Million USD | -15.596% |
| Sector 10, Inc. | 9.84 Million USD | -11432.815% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 16.246% |
| SheerVision, Inc. | 1.43 Million USD | -79224.621% |
| United Health Products, Inc. | 1.99 Million USD | -56704.873% |
| Vasamed, Inc. | 1 Million USD | -112846.882% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -29778.154% |
| Yubo International Biotech Limited | 2.91 Million USD | -38866.528% |